跳至主要内容
临床试验/CTRI/2019/02/017474
CTRI/2019/02/017474尚未招募未知

Efficacy and safety of Curcuma longa as an add-on therapy in type 2 diabetes mellitus: A randomized, double blind, placebo controlled trial

Academic trial JIPMER0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with type 2 diabetes mellitus diagnosed within the past 3 months to 10 years, on a stable dose of metformin and (or) sulfonylureas, for at least past 3 months
  • 2. HbA1c <8%

排除标准

  • 1. Liver dysfunction (AST, ALT > 2 times the upper limit of normal)
  • 2. Renal dysfunction (GFR <60 ml/min)
  • 3. Patient with concurrent illnesses like CAD(Coronary Artery Disease), CVA( cerebrovascular accidents), PVD(Peripheral Vascular Disease), CKD( Chronic Kidney Disease)
  • 4. Pregnant women or lactating mother
  • 5. women in the reproductive age group not practising contraceptive measures.
  • 6. Patients who had participated in other trials in the past three months.
  • 7. Those on other herbal medications.
  • 8. Chronic alcoholics
  • 9. Patients with any active infections including diabetic foot infection
  • 10. History of allergy to any drugs

研究者

发起方
Academic trial JIPMER

相似试验